.FDA declines psychedelic MDMA-assisted therapy for PTSD NBC NewsF.D.A. Decreases to Permit MDMA Therapy, Seeking More Study The New York City TimesFDA Declines Ecstasy-Based Medication The Wall Street JournalFDA declines to permit unfamiliar MDMA treatment to manage post-traumatic stress disorder, along with request for even more trial data CNNFDA declines first experimental to deal with post-traumatic stress disorder, calling for more study The Washington Article.